SEGMENT AND GEOGRAPHIC INFORMATION - Segment Information Of Net Sales And Operating Income (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Net sales	$ 2,753	$ 2,699	$ 2,694	$ 2,490	$ 2,729	$ 2,599	$ 2,591	$ 2,441	$ 10,636	$ 10,360	$ 10,057
Cost of sales									6,652	6,210	6,508
Selling, general and administrative expenses									2,967	2,953	3,097
Research and Development Expense									590	518	450
Total reportable segment operating income									14	707	(2,845)
Operating Segments | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales									5,207	5,011	4,815
Cost of sales									2,867	2,720	2,584
Selling, general and administrative expenses									1,176	1,097	1,069
Research and Development Expense									216	222	202
Other segment items									(2)	0	(2)
Total reportable segment operating income									950	972	962
Operating Segments | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales									2,951	3,013	2,939
Cost of sales									1,464	1,532	1,463
Selling, general and administrative expenses									836	822	827
Research and Development Expense									184	176	155
Other segment items									(1)	0	0
Total reportable segment operating income									468	483	494
Operating Segments | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales									2,411	2,249	2,126
Cost of sales									1,612	1,400	1,293
Selling, general and administrative expenses									396	363	361
Research and Development Expense									91	86	81
Other segment items									(1)	(1)	0
Total reportable segment operating income									313	401	391
Other
Segment Reporting Information [Line Items]
Net sales									$ 67	$ 87	$ 177